Artivion, Inc.

Artivion, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.

Company Details

Employees
886
Founded
-
Address
1655 Roberts Blvd., Nw, Kennesaw,ga 30144,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Kennesaw, GA
Looking for a particular Artivion, Inc. employee's phone or email?

Artivion, Inc. Questions

News

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results - Eastern Progress

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results Eastern Progress

Artivion (NYSE: AORT) sets Nov. 6 results release, 4:30 p.m. ET webcast - Stock Titan

Artivion (NYSE: AORT) sets Nov. 6 results release, 4:30 p.m. ET webcast Stock Titan

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting PR Newswire

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference - PR Newswire

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire

Artivion to Participate in Upcoming Investor Conferences - PR Newswire

Artivion to Participate in Upcoming Investor Conferences PR Newswire

Leading Cardiac Surgery Company Artivion to Share Updates at Morgan Stanley Healthcare Conference - Stock Titan

Leading Cardiac Surgery Company Artivion to Share Updates at Morgan Stanley Healthcare Conference Stock Titan

AdvaMed Code of Ethics® - AdvaMed® - Advanced Medical Technology Association®

AdvaMed Code of Ethics® AdvaMed® - Advanced Medical Technology Association®

How Investors Are Reacting To Artivion (AORT) Clinical Trial Results for Hybrid Aortic Dissection Device - Yahoo Finance

How Investors Are Reacting To Artivion (AORT) Clinical Trial Results for Hybrid Aortic Dissection Device Yahoo Finance

Artivion Reports Second Quarter 2025 Financial Results - PR Newswire

Artivion Reports Second Quarter 2025 Financial Results PR Newswire

Artivion (AORT) Stock Is Up, What You Need To Know - Yahoo Finance

Artivion (AORT) Stock Is Up, What You Need To Know Yahoo Finance

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock - PR Newswire

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock PR Newswire

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PR Newswire

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting PR Newswire

Artivion Reports First Quarter 2025 Financial Results - PR Newswire

Artivion Reports First Quarter 2025 Financial Results PR Newswire

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results - PR Newswire

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - PR Newswire

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis PR Newswire

Artivion Amends Agreements with Endospan - PR Newswire

Artivion Amends Agreements with Endospan PR Newswire

Artivion Obtains $350 Million in Senior Secured Credit Facilities - PR Newswire

Artivion Obtains $350 Million in Senior Secured Credit Facilities PR Newswire

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer - PR Newswire

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer PR Newswire

Artivion Announces Completion of Enrollment in PERSEVERE Trial - PR Newswire

Artivion Announces Completion of Enrollment in PERSEVERE Trial PR Newswire

Artivion (AORT) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance

Artivion (AORT) Tops Q2 Earnings and Revenue Estimates Yahoo Finance

Share Growth And Strong Clinical Results Continue To Support The Artivion Story (NYSE:AORT) - Seeking Alpha

Share Growth And Strong Clinical Results Continue To Support The Artivion Story (NYSE:AORT) Seeking Alpha

Artivion Reports First Quarter 2023 Financial Results - PR Newswire

Artivion Reports First Quarter 2023 Financial Results PR Newswire

Artivion Shipping Processes Disrupted by Ransomware Attack - Medical Device and Diagnostic industry

Artivion Shipping Processes Disrupted by Ransomware Attack Medical Device and Diagnostic industry

Medical Device Maker Artivion Scrambling to Restore Systems After Ransomware Attack - SecurityWeek

Medical Device Maker Artivion Scrambling to Restore Systems After Ransomware Attack SecurityWeek

Artivion says cybersecurity incident has disrupted order, shipping processes - medtechdive.com

Artivion says cybersecurity incident has disrupted order, shipping processes medtechdive.com

Heart Device Maker Artivion Suffers Ransomware Breach - Infosecurity Magazine

Heart Device Maker Artivion Suffers Ransomware Breach Infosecurity Magazine

US medical device giant Artivion says hackers stole files during cybersecurity incident - TechCrunch

US medical device giant Artivion says hackers stole files during cybersecurity incident TechCrunch

Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade

Artivion Surges on Improved 2025 Financial Outlook StocksToTrade

Medical device company says shipping processes disrupted by ransomware attack - The Record from Recorded Future News

Medical device company says shipping processes disrupted by ransomware attack The Record from Recorded Future News

Artivion provides $25M loan to Endospan for stent graft system - MassDevice

Artivion provides $25M loan to Endospan for stent graft system MassDevice

CryoLife Announces Corporate Rebranding and Changes Name to Artivion - PR Newswire

CryoLife Announces Corporate Rebranding and Changes Name to Artivion PR Newswire

Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet - simplywall.st

Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet simplywall.st

Artivion's cyber issues involve encrypted, stolen data - theregister.com

Artivion's cyber issues involve encrypted, stolen data theregister.com

Artivion, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next - simplywall.st

Artivion, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next simplywall.st

CryoLife announces corporate rebranding and changes name to Artivion - Vascular News

CryoLife announces corporate rebranding and changes name to Artivion Vascular News

Artivion gains FDA approval for PerClot, starts transfer to Baxter - MassDevice

Artivion gains FDA approval for PerClot, starts transfer to Baxter MassDevice

Top Artivion, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant